Renal & Urology News

Gene Signature Predicts Worse PCa Patient Survival

Researchers have identified a six-gene signature that can be used in a test to predict survival in men with aggressive prostate cancer (PCa), according to study findings published online in The Lancet ...
ascopubs.org

Baseline parameters of patients with prostate cancer (PCa) initiating a triptorelin treatment for at least 12 months in real life, TALISMAN study interim analysis.

Treatment outcomes for metastatic castration-resistant prostate cancer (mCRPC) following progression on upfront androgen deprivation therapy (ADT) with androgen receptor pathway inhibitors (ARPI) for ...
Medscape

Evaluating Treatments and Corresponding Costs of Prostate Cancer Patients Treated Within an Inpatient or Hospital-based Outpatient Setting

Bayer HealthCare provided support for this research. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial ...
Becker's ASC

High long-term survival rates for postop PCa patients — 5 key points

In a study published in Urologic Oncology, researchers found long-term survival of young men who undergo radical prostatectomy for high-risk prostate cancer is highly satisfactory. Paolo Dell’Oglio, ...